Upcoming Allied Market Research
Colorectal Cancer Liquid Biopsy Market

Colorectal Cancer Liquid Biopsy Market

Size, Share, Competitive Landscape and Trend Analysis Report by Biomarker Type (Circulating Tumor Cells, Circulating Tumor DNA, Extracellular Vesicles, Others), by  Products Services (Kits Reagents, Platforms Instruments, Services) and by End User (Diagnostic Imaging Centers, Hospitals, Academics Research Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A13410
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Colorectal cancer also identified as bowel cancer, rectal cancer, or colon cancer, is any cancer that affects the colon and rectum. Liquid biopsy is a non-invasive alternative to surgical biopsies for the detection of molecular biomarkers. It is carried out to detect cancer at an initial stage. It is also utilized to plan a line of treatment for cancer, find the efficacy of a line of treatment, and detect the recurrence of cancer. Liquid biopsies also help increase capabilities to understand metastatic disease development. A liquid biopsy permits doctors to analyze multiple blood samples over some time, which assists to know the molecular modifications taking place in a tumor.

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.

Owing to such factors, COVID 19 is expected to have a significant impact on the colorectal cancer liquid biopsy market.

Top Impacting Factors

  • Increase in cases of colorectal cancer, and rise in demand for minimally invasive procedure & advanced cancer treatment and procedures are factors that drive the growth of the colorectal cancer liquid biopsy market.
  • In addition, increase in healthcare expenditure; availability of skilled professionals; rise in R&D activities to develop and launch novel therapies in the market; and technological advancements in the field of oncology, are some factors, which boost the market growth for colorectal cancer liquid biopsy.
  • However, recent advances have not yet achieved desired specificity and sensitivity. This may hinder the market growth.
  • Contrarily, growing attention towards liquid biopsy may present new pathways in the industry.

Colorectal Cancer Liquid Biopsy Market Trends

New product launches to flourish the market

In June 2020, Guardant Health presented new data demonstrating that its LUNAR-2 liquid biopsy is a highly sensitive test that can detect early-stage colorectal cancer.

In July 2020, NeoLAB Solid Tumor Liquid Biopsy is designed to test various cancers, including colorectal cancer. The assay is a highly sensitive, specific next-generation sequencing test for genomic profiling.

In October 2020, the FDA approved FoundationOne CDx as a companion diagnostic to detect NTRK fusions in solid tumors like colon and rectal cancer, and identify those who will benefit from the drug VITRAKVI. It can also determine Microsatellite Instability (MSI-H) status, and Tumor Mutational Burden (TMB).

Key Benefits of the Report

  • This study presents the analytical depiction of the colorectal cancer liquid biopsy industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the colorectal cancer liquid biopsy market share.
  • The current market is quantitatively analyzed to highlight the colorectal cancer liquid biopsy market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed colorectal cancer liquid biopsy market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the colorectal cancer liquid biopsy Report

  • Which are the leading players active in the colorectal cancer liquid biopsy market?
  • What are the current trends that will influence the colorectal cancer liquid biopsy market in the next few years?
  • What are the driving factors, restraints, and opportunities of the colorectal cancer liquid biopsy market?
  • What future projections would help in taking further strategic steps?
  • What is "Colorectal cancer liquid biopsy"?
  • What is "Colorectal cancer liquid biopsy" Market prediction in the future?
  • Who are the leading global players in the “Colorectal cancer liquid biopsy" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the “Colorectal cancer liquid biopsy" Market report?

Colorectal Cancer Liquid Biopsy Market Report Highlights

Aspects Details
By Biomarker Type
  • Circulating Tumor Cells
  • Circulating Tumor DNA
  • Extracellular Vesicles
  • Others
By  Products & Services
  • Kits & Reagents
  • Platforms & Instruments
  • Services
By End User
  • Diagnostic & Imaging Centers
  • Hospitals
  • Academics & Research Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Janssen Diagnostics, LLC, Guardant Health, Qiagen, GRAIL, MDX Health SA., Guardant Health Inc., Trovagene Inc., NeoLAB, Myriad Genetics, Biocept, Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Colorectal Cancer Liquid Biopsy Market

Start reading.
This Report and over 71,229+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers